Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
China · Delayed Price · Currency is CNY 26.92
+0.38 (1.43%)
At close: Apr 30, 2026
SHE:301089 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -76.61 | -69.66 | -19.88 | 243.07 | 286.54 | 65.71 |
Depreciation & Amortization | 66.27 | 66.27 | 47.71 | 46.59 | 40.52 | 30.92 |
Other Amortization | 0.88 | 0.88 | 0.83 | 0.52 | 0.47 | 0.57 |
Loss (Gain) From Sale of Assets | 0.42 | 0.42 | 0.01 | - | -0.03 | - |
Asset Writedown & Restructuring Costs | - | - | 1.42 | 4.22 | 1.03 | 1.34 |
Loss (Gain) From Sale of Investments | -4.27 | -4.27 | -1.55 | -7.12 | -5.77 | -0.63 |
Provision & Write-off of Bad Debts | 12.23 | 12.23 | 4.08 | 4.48 | -5.11 | 2.28 |
Other Operating Activities | 50.05 | 16.51 | 9.92 | 11.11 | 12.48 | 9.5 |
Change in Accounts Receivable | -15.07 | -15.07 | 72.83 | -57.67 | -100.76 | -27.49 |
Change in Inventory | -15.35 | -15.35 | 14.55 | 37.75 | -72.92 | -21.38 |
Change in Accounts Payable | -14.45 | -14.45 | -19.28 | -264.08 | 172.6 | -61.71 |
Change in Unearned Revenue | - | - | - | - | - | 16.83 |
Change in Other Net Operating Assets | - | - | - | - | - | 40.99 |
Operating Cash Flow | 0.41 | -26.19 | 102.67 | 26.95 | 268.85 | 58.19 |
Operating Cash Flow Growth | -98.16% | - | 280.91% | -89.98% | 361.99% | -51.51% |
Capital Expenditures | -40.69 | -44.45 | -83.91 | -185.22 | -148.33 | -112.73 |
Sale of Property, Plant & Equipment | - | - | 0.6 | 0.04 | 0.08 | 10 |
Investment in Securities | 10.17 | 114.82 | -60 | 56.57 | -20.4 | -220 |
Other Investing Activities | -1.72 | 0.17 | 3.43 | - | 6.24 | - |
Investing Cash Flow | -32.23 | 70.54 | -139.88 | -128.61 | -162.41 | -322.73 |
Short-Term Debt Issued | - | - | - | - | 90 | 131.4 |
Long-Term Debt Issued | - | 0.01 | - | - | - | - |
Total Debt Issued | 0.01 | 0.01 | - | - | 90 | 131.4 |
Short-Term Debt Repaid | - | - | - | - | - | -193.82 |
Long-Term Debt Repaid | - | -1.22 | -0.94 | -40 | -115.42 | -44.93 |
Total Debt Repaid | -1.22 | -1.22 | -0.94 | -40 | -115.42 | -238.75 |
Net Debt Issued (Repaid) | -1.21 | -1.21 | -0.94 | -40 | -25.42 | -107.35 |
Issuance of Common Stock | - | - | - | 21.6 | - | 558.81 |
Common Dividends Paid | - | - | -31.64 | -50.67 | -14.98 | -7.92 |
Dividends Paid | - | - | -31.64 | -50.67 | -14.98 | -7.92 |
Other Financing Activities | 0.05 | - | - | - | - | -11.3 |
Financing Cash Flow | -1.16 | -1.21 | -32.57 | -69.07 | -40.4 | 432.23 |
Foreign Exchange Rate Adjustments | -0.76 | -0.29 | 0.83 | 0.11 | 0.97 | -0.73 |
Net Cash Flow | -33.74 | 42.86 | -68.95 | -170.62 | 67.01 | 166.97 |
Free Cash Flow | -40.27 | -70.64 | 18.76 | -158.27 | 120.52 | -54.53 |
Free Cash Flow Margin | -10.77% | -18.67% | 4.45% | -18.94% | 15.36% | -10.85% |
Free Cash Flow Per Share | -0.31 | -0.56 | 0.15 | -1.26 | 0.95 | -0.55 |
Cash Income Tax Paid | 10.85 | 17.3 | -7.98 | 237 | 56.09 | 20.74 |
Levered Free Cash Flow | -9.58 | -32.37 | 34.73 | -156.56 | 106.83 | -139.19 |
Unlevered Free Cash Flow | -9.49 | -32.27 | 34.76 | -156.35 | 108.94 | -133.48 |
Change in Working Capital | -48.56 | -48.56 | 60.14 | -275.92 | -61.28 | -51.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.